We are proud to join the Crohn’s & Colitis Foundation, Lupus Research Alliance, National Multiple Sclerosis Society, and Scleroderma Research Foundation as strategic collaborators with Vie Ventures, a new life sciences venture capital firm focused on advancing breakthrough therapies for autoimmune diseases. Vie Ventures bridges traditional biotech venture investing with patient-centric, disease-focused philanthropy, to accelerate innovative treatments for autoimmune diseases and disorders of the immune system.
Read the full announcement from Vie Ventures.
We are proud to join the Crohn’s & Colitis Foundation, Lupus Research Alliance, National Multiple Sclerosis Society, and Scleroderma Research Foundation as strategic collaborators with Vie Ventures, a new life sciences venture capital firm focused on advancing breakthrough therapies for autoimmune diseases. Vie Ventures bridges traditional biotech venture investing with patient-centric, disease-focused philanthropy, to accelerate innovative treatments for autoimmune diseases and disorders of the immune system.
Read the full announcement from Vie Ventures.